Back

Becton Dickinson and Co (BDX)
Health CareBDX · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$189.79
−0.43%Weekly undervalued picks (like BDX)
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$5.82
ROE
6.7%
Gross margin
47.1%
Debt/Equity
0.72x
Revenue growth
5.2%
Becton Dickinson and Co — company intelligence
Earnings surprises
Q3 2026$3.23 vs $3.17 est+1.8%
Q2 2026$2.90 vs $2.80 est+3.5%
Q1 2026$2.91 vs $2.84 est+2.4%
Q4 2025$3.96 vs $3.96 est-0.0%
Analyst consensus · 21 analysts
10 Buy11 Hold0 Sell
Updated Aug 16, 2026
Insider activity · 90 days
4 buys11 sellsnet -42,376 shares
Feld MichaelSell 1,049 · Aug 20, 2026
Polen Thomas E Jrother 43,278 · Aug 13, 2026
Polen Thomas E JrSell 39,126 · Aug 13, 2026
Recent SEC filings
4 — Insider transaction reportAug 24, 2026
4 — Insider transaction reportAug 14, 2026
4 — Insider transaction reportAug 12, 2026
Latest news
What's Going On With Becton Dickinson Stock Wednesday? — Benzinga · 6d ago
Are Wall Street Analysts Predicting Becton, Dickinson and Company Stock Will Climb or Sink? — Yahoo · 1w ago
Becton Dickinson: An Earnings Beat Again As Diverse Clinical Portfolio Keeps On Growing — SeekingAlpha · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks (like BDX)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.